KASINGER JAMES R. bought CRSP
September 22, 2026 · Form 4 insider transaction
KASINGER JAMES R. bought 10,400 shares of CRISPR Therapeutics AG at $13.62 per share, a transaction worth $141.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,400
Price
$13.62
Total value
$141.6K
InsiderKASINGER JAMES R.
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateSeptember 22, 2026
Filing dateSeptember 24, 2026
Shares owned after105,184
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 476 shares acquired under the CRISPR Therapeutics AG 2026 Employee Stock Purchase Plan.